Bioabsorbable polylactic acid-based subcutaneous implant for soft tissue augmentation and volumization. Launched in 2024 as an alternative biostimulatory implant for long-term aesthetic outcomes.
Manufactured by
SciVision Biotech Inc.
Kaohsiung, Taiwan
SciVision Biotech Inc., established in 2001, is a publicly listed company on the Taiwan Stock Exchange since 2013 (Stock Code: 1786). We specialize in the development and manufacturing of premium medical-grade hyaluronic acid products. At SciVision Biotech Inc., we take pride in our self-developed and patented technologies, including the Crosslinked Hyaluronic Acid Platform (CHAP) and auto cross-linking technology. Through these in-house innovations, we have achieved precise control over the characteristics of hyaluronic acid, setting a new industry standard. Our patented auto cross-linking technology represents a breakthrough that eliminates the need for chemical cross-linking agents, positioning SciVision as the only company in the world capable of producing medical-grade crosslinked hyaluronic acid products without adding chemicals. This unique capability allows us to offer a broad portfolio of cross-linking hyaluronic acid products with diverse forms and physical properties.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
LSM-Med S.r.l.
San Marino · 1 relevant product
Samyang Biopharm Corporation
South Korea · 1 relevant product
Wuxi BIOT biology technology co., Ltd.
China · 2 relevant products
52 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →13 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 76 closest product alternatives
LSM-Med S.r.l. · San Marino
Bioresorbable surgical implants manufactured from polylactic acid, biodegradable and manufactured using up to 55 percent less energy than conventional materials.
Samyang Biopharm Corporation · South Korea
A bioimplant device developed using biodegradable polymer technology for orthopedic applications. The implant is designed to support recovery of damaged physical areas and is gradually absorbed by the body.
Wuxi BIOT biology technology co., Ltd. · China
An NMPA-approved collagen protein implant for medical aesthetic and tissue repair applications. The implant utilizes bioactive collagen with complete triple helix structure for safe and effective tissue augmentation.
73 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products